Total Funding
7
18
Total FundingSeries C raised
Growth Score
-6 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
238562
Regenesis Biomedical focuses on the development of non-invasive regenerative medicine products.
Henry Newman: DirectorPast Role: Coopers & Lybrand, CPA
About the Company
Regenesis Biomedical a medical technology company that focuses on developing and marketing noninvasive regenerative medicine products. The company offers Provant Therapy System, a medical device that aids in reduction of pain and swelling of skin and soft tissues following surgery. Its customers include health care facilities and providers that
serve patients being treated by acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home healthcare agencies, and wound care clinics.
Regenesis Biomedical was founded in 1996 and is headquartered in Scottsdale, Arizona.
Women Founded
Women Led
